FDA OK's COVID booster shot for immunocompromised
The FDA determined that patients with a high level of compromised immunity can receive a third dose of the vaccines from Pfizer and Moderna at least 28 days after getting their second shot.
The FDA determined that patients with a high level of compromised immunity can receive a third dose of the vaccines from Pfizer and Moderna at least 28 days after getting their second shot.